Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Hesperos, Intabio, UAMS Translational Research Institute. Among the most popular fund investment industries, there are Association, Biopharma.
Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is generally included in 2-6 deals every year. The high activity for fund was in 2018.
The standard case for the fund is to invest in rounds with 1 partaker. Despite the National Center for Advancing Translational Sciences(NCATS), startups are often financed by Genoa Ventures. In the next rounds fund is usually obtained by Northpond Ventures, National Institutes of Health, Genoa Ventures.
Related Funds
| Fund Name | Location |
| Angels in MedCity | England, London, United Kingdom |
| BellSouth | Atlanta, Georgia, United States |
| BZ Fund | Beijing, Beijing, China |
| Center for Innovative Technology | Herndon, United States, Virginia |
| Deqing Jingshi | China, Deqing, Zhejiang |
| eCAPITAL entrepreneurial Partners AG | Germany, Münster, Nordrhein-Westfalen |
| Flash Forward Ventures | United States, Vienna, Virginia |
| Kamet | France, Ile-de-France, Paris |
| Malik Radix Healthcare | Delhi, Delhi, India |
| Private investors | - |
| Rearden Capital Management LLC | - |
| Scout Analytics | Issaquah, United States, Washington |
| Sichuan Xinhua Distribution Group | Chengdu, China, Sichuan |
| signals Venture Capital | Berlin, Berlin, Germany |
| TechCrunch | California, San Francisco, United States |
| Tempo Beverages Cyprus Ltd. | Cyprus, Limassol |
| Visa Europe | England, London, United Kingdom |
| Waverly Capital | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 